You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恆指考驗26,200獲支持倒升 藥明生物及安踏續升2%-5.6%再破頂
阿思達克 12-22 11:07
英國出現傳播力更強新冠病毒變種,引發市場恐慌,但美國國會就新一輪抗疫刺激經濟方案達共識,加上聯儲局批准大型銀行派發股息限制及明年首季恢復回購股份,道指昨晚在銀行股重現買盤及部分科技股反彈支持收復曾挫423點所有失地逆市倒升0.1%重越30,200關。亞太區股市今天除新西蘭回升1.4%及港股反覆回穩外,全部受壓。

恆指承過去兩連跌勢,今早低開45點或0.2%報26,260,最低見26,204獲承接,掉頭高見26,365,現造26,321,倒升14點,成交額504億元。

安踏(02020.HK)承昨天扭兩連跌重越108元勢,今早股價曾一舉升破20天與10天線(108.9元及109.6元)及11月19日盤中所創紀錄高位114.3元,最高見114.5元,現造114元,續升5.6%,為最強藍籌,成交435萬股,涉資近4.78億元。安踏公布,公司持股52.7%合營AS Holding,擬以總代價4.2億美元悉售旗下器械健身附屬Precor Incorporated,預計合營出售事項將獲利約2,000萬美元。

藥明生物(02269.HK)連續第二天反覆創紀錄高,高低見94元/90.45元,現造92.5元,續升2%,公司宣布收購拜耳德國生物藥原液製造工廠。此外,蘋果昨晚反覆升逾1%,舜宇(02382.HK)扭兩連跌重越10天線,最高見160.8元,現造159.4元,回升3.7%。小米(01810.HK)續升2.4%報30元,主席雷軍稱即將於下周一(28日)發布新手機「小米11」,並指是高端旗艦的再次突破。

相反,受困於英國疫情急劇惡化的長和(00001.HK)、長實集團(01113.HK)、萬洲(00288.HK)、濠賭股銀娛(00027.HK)及金沙(01928.HK)跌逾2%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account